LIM
AZN icon

Longfellow Investment Management’s AstraZeneca AZN Stock Holding History

Longfellow Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,883
Closed -$3.82M – 240
2025
Q3 		$3.82M Buy
+24,883
New +$3.77M 0.91% 17

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Longfellow Investment Management's AZN Position: Q4 2025 in Review

Longfellow Investment Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 24,883 shares — an estimated $3.82M sold.

Longfellow Investment Management first reported a position in AZN in Q3 2025 and held it in 1 quarter. The position peaked at $3.82M in Q3 2025. 1,407 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Longfellow Investment Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Longfellow Investment Management sold 24,883 AstraZeneca shares in Q4 2025, an estimated $3.82M.
  • Longfellow Investment Management first reported a position in AstraZeneca in Q3 2025 and held it in 1 quarter.
  • Longfellow Investment Management's AstraZeneca position peaked at $3.82M in Q3 2025.
  • 1,407 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Longfellow Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.